2.90 USD
↗ 0.05 (1.75%)AT CLOSE (03:59 PM EDT)
Seres Therapeutics, Inc.
MCRBNASDAQ • USD
2.92
↗ 0.02 (0.72%)
POST MARKET (AS OF 06:03 PM EDT)
Post Market
AS OF 06:03 PM EDT
2.92
↗ 0.02 (0.72%)
Market: OPEN
Seres Therapeutics, Inc. (MCRB) trades at $2.92 per share. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics place MCRB at a fair price relative to peers.
Technical & fundamental data as of Oct 6, 2026.
Open?$2.88
High?$3.02
Low?$2.80
Prev. Close?$2.85
Volume?76.4K
Avg. Volume?65.1K
VWAP?$2.88
Rel. Volume?1.17x
Bid / Ask
Bid?$2.40 × 100
Ask?$3.53 × 100
Spread?$1.13
Midpoint?$2.97
Valuation & Ratios
Market Cap?28.6M
Shares Out?10.0M
Float?7.1M
Float %?71.0%
P/E Ratio?N/A
P/B Ratio?0.83
EPS?-$2.24
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.
Employees
66
Market Cap
28.6M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2015-06-26
Address
200 SIDNEY STREET
CAMBRIDGE, MA 02139
Phone: 617 945 9626
CAMBRIDGE, MA 02139
Phone: 617 945 9626
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?62
Short Sent.?59
Piotroski F-Score?0/9Weak
Altman Z-Score?-15.80Distress
Confidence?50%Low
Short InterestHigh
Short % of Float?4.27%Low
Short Interest?301.3K
Days to Cover?5.7
Free Float7.1M
Avg Daily Volume52.6K
Settlement Date2026-09-15
Financial Health
Current Ratio?2.11Strong
Quick Ratio?2.11Strong
Cash Ratio?0.78Adequate
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?0.83CHEAP▾
Peers100
S&P97
P/S?15.20HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-0.2CHEAP▾
S&P97
EV/Sales?6.92HIGH▾
Peers100
S&P20
Returns & Efficiency
ROE?-65.1%WEAK▾
S&P3
ROA?-22.1%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-51295000
Enterprise Value?$13.0M
Fundamentals ratios updated end of day